1st Annual Neuroscience BioPartnering & Investment Forum - Feb. 23, 2016

http://www.sachsforum.com/1st-annual-neurosci...ences.html

Agenda:
Advances in Parkinson’s Disease and Lewy Body Dementia
13.35 - Chaired: Ginger Johnson, Vice President, Defined Health

Panellists:
Andrew Singleton, Chief, Molecular Genetics Section and Laboratory of Neurogenetics, NIA, NIH
Gerald Commissiong , President & CEO, Amarantus BioScience Holdings, Inc.
Kees Been, CEO, Lysosomal Therapeutics
Timo Veromaa, President and CEO, Biotie Therapies Corp.
Todd Sherer, CEO, Michael J. Fox Foundation

http://www.sachsforum.com/uploads/5/1/9/6/519...da_v.5.pdf

Presenting Track D
16.40- Moderated by:
Amarantus BioScience Holdings, Inc.